Organization record
EIKON THERAPEUTICS, INC.
All evidence-backed facts for this organization, identity resolved across official registers.
Facts on record
Newest first; every row links to its evidence page.
| Fact | Value | Period | Source |
|---|---|---|---|
| accounts_payable | {"amount": 6564000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} | 2026-06-30 | sec_edgar |
| accounts_payable | {"amount": 6005000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} | 2026-03-31 | sec_edgar |
| accounts_payable | {"amount": 681000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} | 2025-12-31 | sec_edgar |
| capex | {"amount": 513000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "curre | 2026-06-30 | sec_edgar |
| capex | {"amount": 262000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "curre | 2026-03-31 | sec_edgar |
| capex | {"amount": 44074000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "cur | 2025-06-30 | sec_edgar |
| capex | {"amount": 22358000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "cur | 2025-03-31 | sec_edgar |
| cash_and_equivalents | {"amount": 142613000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currenc | 2026-06-30 | sec_edgar |
| cash_and_equivalents | {"amount": 161154000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currenc | 2026-03-31 | sec_edgar |
| cash_and_equivalents | {"amount": 104901000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currenc | 2025-12-31 | sec_edgar |
| cash_and_equivalents | {"amount": 136564000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currenc | 2025-06-30 | sec_edgar |
| cash_and_equivalents | {"amount": 204582000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currenc | 2025-03-31 | sec_edgar |
| cashflow_financing | {"amount": 349333000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "cu | 2026-06-30 | sec_edgar |
| cashflow_financing | {"amount": 349308000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "cu | 2026-03-31 | sec_edgar |
| cashflow_financing | {"amount": 350753000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "cu | 2025-06-30 | sec_edgar |
| cashflow_financing | {"amount": 350234000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "cu | 2025-03-31 | sec_edgar |
| cashflow_investing | {"amount": -156788000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "c | 2026-06-30 | sec_edgar |
| cashflow_investing | {"amount": -203217000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "c | 2026-03-31 | sec_edgar |
| cashflow_investing | {"amount": -249730000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "c | 2025-06-30 | sec_edgar |
| cashflow_investing | {"amount": -213854000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "c | 2025-03-31 | sec_edgar |
| cashflow_operating | {"amount": -154759000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "c | 2026-06-30 | sec_edgar |
| cashflow_operating | {"amount": -89801000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "cu | 2026-03-31 | sec_edgar |
| cashflow_operating | {"amount": -87257000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "cu | 2025-06-30 | sec_edgar |
| cashflow_operating | {"amount": -54521000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "cu | 2025-03-31 | sec_edgar |
| common_shares_issued | {"unit": "shares", "value": 54148887, "concept": "us-gaap:CommonStockSharesIssued"} | 2026-06-30 | sec_edgar |
| common_shares_issued | {"unit": "shares", "value": 54138555, "concept": "us-gaap:CommonStockSharesIssued"} | 2026-03-31 | sec_edgar |
| common_shares_issued | {"unit": "shares", "value": 3068490, "concept": "us-gaap:CommonStockSharesIssued"} | 2025-12-31 | sec_edgar |
| common_shares_outstanding | {"unit": "shares", "value": 54165030, "concept": "dei:EntityCommonStockSharesOutstanding"} | 2026-08-03 | sec_edgar |
| common_shares_outstanding | {"unit": "shares", "value": 54148887, "concept": "us-gaap:CommonStockSharesOutstanding"} | 2026-06-30 | sec_edgar |
| common_shares_outstanding | {"unit": "shares", "value": 54138628, "concept": "dei:EntityCommonStockSharesOutstanding"} | 2026-05-01 | sec_edgar |
| common_shares_outstanding | {"unit": "shares", "value": 54138555, "concept": "us-gaap:CommonStockSharesOutstanding"} | 2026-03-31 | sec_edgar |
| common_shares_outstanding | {"unit": "shares", "value": 3068490, "concept": "us-gaap:CommonStockSharesOutstanding"} | 2025-12-31 | sec_edgar |
| current_assets | {"amount": 546978000, "concept": "us-gaap:AssetsCurrent", "currency": "USD"} | 2026-06-30 | sec_edgar |
| current_assets | {"amount": 529501000, "concept": "us-gaap:AssetsCurrent", "currency": "USD"} | 2026-03-31 | sec_edgar |
| current_assets | {"amount": 348917000, "concept": "us-gaap:AssetsCurrent", "currency": "USD"} | 2025-12-31 | sec_edgar |
| current_liabilities | {"amount": 55296000, "concept": "us-gaap:LiabilitiesCurrent", "currency": "USD"} | 2026-06-30 | sec_edgar |
| current_liabilities | {"amount": 45064000, "concept": "us-gaap:LiabilitiesCurrent", "currency": "USD"} | 2026-03-31 | sec_edgar |
| current_liabilities | {"amount": 55007000, "concept": "us-gaap:LiabilitiesCurrent", "currency": "USD"} | 2025-12-31 | sec_edgar |
| dei:EntityCommonStockSharesOutstanding | {"unit": "shares", "value": 54165030} | 2026-08-03 | sec_edgar |
| dei:EntityCommonStockSharesOutstanding | {"unit": "shares", "value": 54138628} | 2026-05-01 | sec_edgar |
| eps_basic | {"per": "shares", "amount": -1.63, "concept": "us-gaap:EarningsPerShareBasic", "currency": | 2026-06-30 | sec_edgar |
| eps_basic | {"per": "shares", "amount": -3.9, "concept": "us-gaap:EarningsPerShareBasic", "currency": | 2026-06-30 | sec_edgar |
| eps_basic | {"per": "shares", "amount": -2.46, "concept": "us-gaap:EarningsPerShareBasic", "currency": | 2026-03-31 | sec_edgar |
| eps_basic | {"per": "shares", "amount": -36.94, "concept": "us-gaap:EarningsPerShareBasic", "currency" | 2025-06-30 | sec_edgar |
| eps_basic | {"per": "shares", "amount": -65.08, "concept": "us-gaap:EarningsPerShareBasic", "currency" | 2025-06-30 | sec_edgar |
| eps_basic | {"per": "shares", "amount": -26.91, "concept": "us-gaap:EarningsPerShareBasic", "currency" | 2025-03-31 | sec_edgar |
| eps_diluted | {"per": "shares", "amount": -1.63, "concept": "us-gaap:EarningsPerShareDiluted", "currency | 2026-06-30 | sec_edgar |
| eps_diluted | {"per": "shares", "amount": -3.9, "concept": "us-gaap:EarningsPerShareDiluted", "currency" | 2026-06-30 | sec_edgar |
| eps_diluted | {"per": "shares", "amount": -2.46, "concept": "us-gaap:EarningsPerShareDiluted", "currency | 2026-03-31 | sec_edgar |
| eps_diluted | {"per": "shares", "amount": -36.94, "concept": "us-gaap:EarningsPerShareDiluted", "currenc | 2025-06-30 | sec_edgar |
| eps_diluted | {"per": "shares", "amount": -65.08, "concept": "us-gaap:EarningsPerShareDiluted", "currenc | 2025-06-30 | sec_edgar |
| eps_diluted | {"per": "shares", "amount": -26.91, "concept": "us-gaap:EarningsPerShareDiluted", "currenc | 2025-03-31 | sec_edgar |
| industry_sic | {"code": "2836", "scheme": "SIC", "description": "Biological Products, (No Diagnostic Subs | sec_edgar | |
| marketable_securities | {"amount": 388565000, "concept": "us-gaap:MarketableSecuritiesCurrent", "currency": "USD"} | 2026-06-30 | sec_edgar |
| marketable_securities | {"amount": 351028000, "concept": "us-gaap:MarketableSecuritiesCurrent", "currency": "USD"} | 2026-03-31 | sec_edgar |
| marketable_securities | {"amount": 231074000, "concept": "us-gaap:MarketableSecuritiesCurrent", "currency": "USD"} | 2025-12-31 | sec_edgar |
| net_income | {"amount": -88409000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} | 2026-06-30 | sec_edgar |
| net_income | {"amount": -171367000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} | 2026-06-30 | sec_edgar |
| net_income | {"amount": -82958000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} | 2026-03-31 | sec_edgar |
| net_income | {"amount": -105211000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} | 2025-06-30 | sec_edgar |
| net_income | {"amount": -173454000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} | 2025-06-30 | sec_edgar |
| net_income | {"amount": -68243000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} | 2025-03-31 | sec_edgar |
| operating_expenses | {"amount": 93394000, "concept": "us-gaap:OperatingExpenses", "currency": "USD"} | 2026-06-30 | sec_edgar |
| operating_expenses | {"amount": 180731000, "concept": "us-gaap:OperatingExpenses", "currency": "USD"} | 2026-06-30 | sec_edgar |
| operating_expenses | {"amount": 87337000, "concept": "us-gaap:OperatingExpenses", "currency": "USD"} | 2026-03-31 | sec_edgar |
| operating_expenses | {"amount": 109643000, "concept": "us-gaap:OperatingExpenses", "currency": "USD"} | 2025-06-30 | sec_edgar |
| operating_expenses | {"amount": 181026000, "concept": "us-gaap:OperatingExpenses", "currency": "USD"} | 2025-06-30 | sec_edgar |
| operating_expenses | {"amount": 71383000, "concept": "us-gaap:OperatingExpenses", "currency": "USD"} | 2025-03-31 | sec_edgar |
| operating_income | {"amount": -93394000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} | 2026-06-30 | sec_edgar |
| operating_income | {"amount": -180731000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} | 2026-06-30 | sec_edgar |
| operating_income | {"amount": -87337000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} | 2026-03-31 | sec_edgar |
| operating_income | {"amount": -109643000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} | 2025-06-30 | sec_edgar |
| operating_income | {"amount": -181026000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} | 2025-06-30 | sec_edgar |
| operating_income | {"amount": -71383000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} | 2025-03-31 | sec_edgar |
| operating_lease_liability | {"amount": 252219000, "concept": "us-gaap:OperatingLeaseLiability", "currency": "USD"} | 2026-06-30 | sec_edgar |
| operating_lease_liability | {"amount": 254831000, "concept": "us-gaap:OperatingLeaseLiability", "currency": "USD"} | 2026-03-31 | sec_edgar |
| ppe_net | {"amount": 133071000, "concept": "us-gaap:PropertyPlantAndEquipmentNet", "currency": "USD" | 2026-06-30 | sec_edgar |
| ppe_net | {"amount": 138067000, "concept": "us-gaap:PropertyPlantAndEquipmentNet", "currency": "USD" | 2026-03-31 | sec_edgar |
| ppe_net | {"amount": 142898000, "concept": "us-gaap:PropertyPlantAndEquipmentNet", "currency": "USD" | 2025-12-31 | sec_edgar |
| profit_loss | {"amount": -171367000, "concept": "us-gaap:ProfitLoss", "currency": "USD"} | 2026-06-30 | sec_edgar |
| profit_loss | {"amount": -82958000, "concept": "us-gaap:ProfitLoss", "currency": "USD"} | 2026-03-31 | sec_edgar |
| profit_loss | {"amount": -173454000, "concept": "us-gaap:ProfitLoss", "currency": "USD"} | 2025-06-30 | sec_edgar |
| profit_loss | {"amount": -68243000, "concept": "us-gaap:ProfitLoss", "currency": "USD"} | 2025-03-31 | sec_edgar |
| retained_earnings | {"amount": -1091876000, "concept": "us-gaap:RetainedEarningsAccumulatedDeficit", "currency | 2026-06-30 | sec_edgar |
| retained_earnings | {"amount": -1003467000, "concept": "us-gaap:RetainedEarningsAccumulatedDeficit", "currency | 2026-03-31 | sec_edgar |
| retained_earnings | {"amount": -920509000, "concept": "us-gaap:RetainedEarningsAccumulatedDeficit", "currency" | 2025-12-31 | sec_edgar |
| rnd_expense | {"amount": 75460000, "concept": "us-gaap:ResearchAndDevelopmentExpense", "currency": "USD" | 2026-06-30 | sec_edgar |
| rnd_expense | {"amount": 145507000, "concept": "us-gaap:ResearchAndDevelopmentExpense", "currency": "USD | 2026-06-30 | sec_edgar |
| rnd_expense | {"amount": 70047000, "concept": "us-gaap:ResearchAndDevelopmentExpense", "currency": "USD" | 2026-03-31 | sec_edgar |
| rnd_expense | {"amount": 69189000, "concept": "us-gaap:ResearchAndDevelopmentExpense", "currency": "USD" | 2025-06-30 | sec_edgar |
| rnd_expense | {"amount": 125776000, "concept": "us-gaap:ResearchAndDevelopmentExpense", "currency": "USD | 2025-06-30 | sec_edgar |
| rnd_expense | {"amount": 56587000, "concept": "us-gaap:ResearchAndDevelopmentExpense", "currency": "USD" | 2025-03-31 | sec_edgar |
| sga_expense | {"amount": 17934000, "concept": "us-gaap:GeneralAndAdministrativeExpense", "currency": "US | 2026-06-30 | sec_edgar |
| sga_expense | {"amount": 35224000, "concept": "us-gaap:GeneralAndAdministrativeExpense", "currency": "US | 2026-06-30 | sec_edgar |
| sga_expense | {"amount": 17290000, "concept": "us-gaap:GeneralAndAdministrativeExpense", "currency": "US | 2026-03-31 | sec_edgar |
| sga_expense | {"amount": 40454000, "concept": "us-gaap:GeneralAndAdministrativeExpense", "currency": "US | 2025-06-30 | sec_edgar |
| sga_expense | {"amount": 55250000, "concept": "us-gaap:GeneralAndAdministrativeExpense", "currency": "US | 2025-06-30 | sec_edgar |
| sga_expense | {"amount": 14796000, "concept": "us-gaap:GeneralAndAdministrativeExpense", "currency": "US | 2025-03-31 | sec_edgar |
| share_based_compensation | {"amount": 6996000, "concept": "us-gaap:ShareBasedCompensation", "currency": "USD"} | 2026-06-30 | sec_edgar |
| share_based_compensation | {"amount": 2777000, "concept": "us-gaap:ShareBasedCompensation", "currency": "USD"} | 2026-03-31 | sec_edgar |
| share_based_compensation | {"amount": 10183000, "concept": "us-gaap:ShareBasedCompensation", "currency": "USD"} | 2025-06-30 | sec_edgar |
| share_based_compensation | {"amount": 2970000, "concept": "us-gaap:ShareBasedCompensation", "currency": "USD"} | 2025-03-31 | sec_edgar |
| shares_wavg_basic | {"unit": "shares", "value": 54143162, "concept": "us-gaap:WeightedAverageNumberOfSharesOut | 2026-06-30 | sec_edgar |
| shares_wavg_basic | {"unit": "shares", "value": 43978373, "concept": "us-gaap:WeightedAverageNumberOfSharesOut | 2026-06-30 | sec_edgar |
| shares_wavg_basic | {"unit": "shares", "value": 33700550, "concept": "us-gaap:WeightedAverageNumberOfSharesOut | 2026-03-31 | sec_edgar |
| shares_wavg_basic | {"unit": "shares", "value": 2848529, "concept": "us-gaap:WeightedAverageNumberOfSharesOuts | 2025-06-30 | sec_edgar |
| shares_wavg_basic | {"unit": "shares", "value": 2809691, "concept": "us-gaap:WeightedAverageNumberOfSharesOuts | 2025-06-30 | sec_edgar |
| shares_wavg_basic | {"unit": "shares", "value": 2770352, "concept": "us-gaap:WeightedAverageNumberOfSharesOuts | 2025-03-31 | sec_edgar |
| shares_wavg_diluted | {"unit": "shares", "value": 54143162, "concept": "us-gaap:WeightedAverageNumberOfDilutedSh | 2026-06-30 | sec_edgar |
| shares_wavg_diluted | {"unit": "shares", "value": 43978373, "concept": "us-gaap:WeightedAverageNumberOfDilutedSh | 2026-06-30 | sec_edgar |
| shares_wavg_diluted | {"unit": "shares", "value": 33700550, "concept": "us-gaap:WeightedAverageNumberOfDilutedSh | 2026-03-31 | sec_edgar |
| shares_wavg_diluted | {"unit": "shares", "value": 2848529, "concept": "us-gaap:WeightedAverageNumberOfDilutedSha | 2025-06-30 | sec_edgar |
| shares_wavg_diluted | {"unit": "shares", "value": 2809691, "concept": "us-gaap:WeightedAverageNumberOfDilutedSha | 2025-06-30 | sec_edgar |
| shares_wavg_diluted | {"unit": "shares", "value": 2770352, "concept": "us-gaap:WeightedAverageNumberOfDilutedSha | 2025-03-31 | sec_edgar |
| stockholders_equity | {"amount": 466500000, "concept": "us-gaap:StockholdersEquity", "currency": "USD"} | 2026-06-30 | sec_edgar |
| stockholders_equity | {"amount": 550671000, "concept": "us-gaap:StockholdersEquity", "currency": "USD"} | 2026-03-31 | sec_edgar |
| stockholders_equity | {"amount": -879034000, "concept": "us-gaap:StockholdersEquity", "currency": "USD"} | 2025-12-31 | sec_edgar |
| stockholders_equity | {"amount": -737501000, "concept": "us-gaap:StockholdersEquity", "currency": "USD"} | 2025-06-30 | sec_edgar |
| stockholders_equity | {"amount": -640137000, "concept": "us-gaap:StockholdersEquity", "currency": "USD"} | 2025-03-31 | sec_edgar |
| stockholders_equity | {"amount": -571930000, "concept": "us-gaap:StockholdersEquity", "currency": "USD"} | 2024-12-31 | sec_edgar |
| total_assets | {"amount": 779570000, "concept": "us-gaap:Assets", "currency": "USD"} | 2026-06-30 | sec_edgar |
| total_assets | {"amount": 850826000, "concept": "us-gaap:Assets", "currency": "USD"} | 2026-03-31 | sec_edgar |
| total_assets | {"amount": 594734000, "concept": "us-gaap:Assets", "currency": "USD"} | 2025-12-31 | sec_edgar |
| total_liabilities | {"amount": 313070000, "concept": "us-gaap:Liabilities", "currency": "USD"} | 2026-06-30 | sec_edgar |
| total_liabilities | {"amount": 300155000, "concept": "us-gaap:Liabilities", "currency": "USD"} | 2026-03-31 | sec_edgar |
| total_liabilities | {"amount": 312298000, "concept": "us-gaap:Liabilities", "currency": "USD"} | 2025-12-31 | sec_edgar |
| total_liabilities_and_equity | {"amount": 779570000, "concept": "us-gaap:LiabilitiesAndStockholdersEquity", "currency": " | 2026-06-30 | sec_edgar |
| total_liabilities_and_equity | {"amount": 850826000, "concept": "us-gaap:LiabilitiesAndStockholdersEquity", "currency": " | 2026-03-31 | sec_edgar |
| total_liabilities_and_equity | {"amount": 594734000, "concept": "us-gaap:LiabilitiesAndStockholdersEquity", "currency": " | 2025-12-31 | sec_edgar |
| xbrl:AccountsPayableAndOtherAccruedLiabilitiesCurrent | {"amount": 39287000, "currency": "USD"} | 2026-06-30 | sec_edgar |
| xbrl:AccountsPayableAndOtherAccruedLiabilitiesCurrent | {"amount": 29319000, "currency": "USD"} | 2026-03-31 | sec_edgar |
| xbrl:AccountsPayableAndOtherAccruedLiabilitiesCurrent | {"amount": 44298000, "currency": "USD"} | 2025-12-31 | sec_edgar |
| xbrl:AccountsPayableCurrent | {"amount": 6564000, "currency": "USD"} | 2026-06-30 | sec_edgar |
| xbrl:AccountsPayableCurrent | {"amount": 6005000, "currency": "USD"} | 2026-03-31 | sec_edgar |
| xbrl:AccountsPayableCurrent | {"amount": 681000, "currency": "USD"} | 2025-12-31 | sec_edgar |
| xbrl:AccretionAmortizationOfDiscountsAndPremiumsInvestments | {"amount": 1216000, "currency": "USD"} | 2026-06-30 | sec_edgar |
| xbrl:AccretionAmortizationOfDiscountsAndPremiumsInvestments | {"amount": 827000, "currency": "USD"} | 2026-03-31 | sec_edgar |
| xbrl:AccretionAmortizationOfDiscountsAndPremiumsInvestments | {"amount": 3281000, "currency": "USD"} | 2025-06-30 | sec_edgar |
| xbrl:AccretionAmortizationOfDiscountsAndPremiumsInvestments | {"amount": 1234000, "currency": "USD"} | 2025-03-31 | sec_edgar |
| xbrl:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | {"amount": 53214000, "currency": "USD"} | 2026-06-30 | sec_edgar |
| xbrl:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | {"amount": 48094000, "currency": "USD"} | 2026-03-31 | sec_edgar |
| xbrl:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | {"amount": 42914000, "currency": "USD"} | 2025-12-31 | sec_edgar |
| xbrl:AdditionalPaidInCapitalCommonStock | {"amount": 1558371000, "currency": "USD"} | 2026-06-30 | sec_edgar |
| xbrl:AdditionalPaidInCapitalCommonStock | {"amount": 1554133000, "currency": "USD"} | 2026-03-31 | sec_edgar |
| xbrl:AdditionalPaidInCapitalCommonStock | {"amount": 41475000, "currency": "USD"} | 2025-12-31 | sec_edgar |
| xbrl:AdjustmentsToAdditionalPaidInCapitalWarrantIssued | {"amount": 6300000, "currency": "USD"} | 2025-12-31 | sec_edgar |
| xbrl:AllocatedShareBasedCompensationExpense | {"amount": 4219000, "currency": "USD"} | 2026-06-30 | sec_edgar |
| xbrl:AllocatedShareBasedCompensationExpense | {"amount": 6996000, "currency": "USD"} | 2026-06-30 | sec_edgar |
| xbrl:AllocatedShareBasedCompensationExpense | {"amount": 2777000, "currency": "USD"} | 2026-03-31 | sec_edgar |
| xbrl:AllocatedShareBasedCompensationExpense | {"amount": 7213000, "currency": "USD"} | 2025-06-30 | sec_edgar |
| xbrl:AllocatedShareBasedCompensationExpense | {"amount": 10183000, "currency": "USD"} | 2025-06-30 | sec_edgar |
| xbrl:AllocatedShareBasedCompensationExpense | {"amount": 2970000, "currency": "USD"} | 2025-03-31 | sec_edgar |
| xbrl:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | {"unit": "shares", "value": 8659090} | 2026-06-30 | sec_edgar |
| xbrl:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | {"unit": "shares", "value": 8659090} | 2026-06-30 | sec_edgar |
| xbrl:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | {"unit": "shares", "value": 8262751} | 2026-03-31 | sec_edgar |
| xbrl:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | {"unit": "shares", "value": 36341278} | 2025-06-30 | sec_edgar |
| xbrl:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | {"unit": "shares", "value": 36341278} | 2025-06-30 | sec_edgar |
| xbrl:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | {"unit": "shares", "value": 33563186} | 2025-03-31 | sec_edgar |
| xbrl:Assets | {"amount": 779570000, "currency": "USD"} | 2026-06-30 | sec_edgar |
| xbrl:Assets | {"amount": 850826000, "currency": "USD"} | 2026-03-31 | sec_edgar |
| xbrl:Assets | {"amount": 594734000, "currency": "USD"} | 2025-12-31 | sec_edgar |
| xbrl:AssetsCurrent | {"amount": 546978000, "currency": "USD"} | 2026-06-30 | sec_edgar |
| xbrl:AssetsCurrent | {"amount": 529501000, "currency": "USD"} | 2026-03-31 | sec_edgar |
| xbrl:AssetsCurrent | {"amount": 348917000, "currency": "USD"} | 2025-12-31 | sec_edgar |
| xbrl:CapitalExpendituresIncurredButNotYetPaid | {"amount": 102000, "currency": "USD"} | 2026-06-30 | sec_edgar |
| xbrl:CapitalExpendituresIncurredButNotYetPaid | {"amount": 221000, "currency": "USD"} | 2026-03-31 | sec_edgar |
| xbrl:CapitalExpendituresIncurredButNotYetPaid | {"amount": 279000, "currency": "USD"} | 2025-06-30 | sec_edgar |
| xbrl:CapitalExpendituresIncurredButNotYetPaid | {"amount": 9346000, "currency": "USD"} | 2025-03-31 | sec_edgar |
| xbrl:CashAndCashEquivalentsAtCarryingValue | {"amount": 142613000, "currency": "USD"} | 2026-06-30 | sec_edgar |
| xbrl:CashAndCashEquivalentsAtCarryingValue | {"amount": 161154000, "currency": "USD"} | 2026-03-31 | sec_edgar |
| xbrl:CashAndCashEquivalentsAtCarryingValue | {"amount": 104901000, "currency": "USD"} | 2025-12-31 | sec_edgar |
| xbrl:CashAndCashEquivalentsAtCarryingValue | {"amount": 136564000, "currency": "USD"} | 2025-06-30 | sec_edgar |
| xbrl:CashAndCashEquivalentsAtCarryingValue | {"amount": 204582000, "currency": "USD"} | 2025-03-31 | sec_edgar |
| xbrl:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | {"amount": 150858000, "currency": "USD"} | 2026-06-30 | sec_edgar |
| xbrl:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | {"amount": 169362000, "currency": "USD"} | 2026-03-31 | sec_edgar |
| xbrl:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | {"amount": 113072000, "currency": "USD"} | 2025-12-31 | sec_edgar |
| xbrl:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | {"amount": 144644000, "currency": "USD"} | 2025-06-30 | sec_edgar |
| xbrl:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | {"amount": 212737000, "currency": "USD"} | 2025-03-31 | sec_edgar |
| xbrl:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | {"amount": 130878000, "currency": "USD"} | 2024-12-31 | sec_edgar |
| xbrl:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | {"amount": 37786000, "currency": "USD"} | 2026-06-30 | sec_edgar |
| xbrl:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | {"amount": 56290000, "currency": "USD"} | 2026-03-31 | sec_edgar |
| xbrl:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | {"amount": 13766000, "currency": "USD"} | 2025-06-30 | sec_edgar |
| xbrl:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | {"amount": 81859000, "currency": "USD"} | 2025-03-31 | sec_edgar |
| xbrl:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | {"per": "shares", "amount": 43.59, "currency": "USD"} | 2025-02-28 | sec_edgar |
| xbrl:CommonStockCapitalSharesReservedForFutureIssuance | {"unit": "shares", "value": 11061120} | 2026-06-30 | sec_edgar |
| xbrl:CommonStockCapitalSharesReservedForFutureIssuance | {"unit": "shares", "value": 11071452} | 2026-03-31 | sec_edgar |
| xbrl:CommonStockCapitalSharesReservedForFutureIssuance | {"unit": "shares", "value": 37557964} | 2025-12-31 | sec_edgar |
| xbrl:CommonStockParOrStatedValuePerShare | {"per": "shares", "amount": 0.0001, "currency": "USD"} | 2026-06-30 | sec_edgar |
| xbrl:CommonStockParOrStatedValuePerShare | {"per": "shares", "amount": 0.0001, "currency": "USD"} | 2026-03-31 | sec_edgar |
| xbrl:CommonStockParOrStatedValuePerShare | {"per": "shares", "amount": 0.0001, "currency": "USD"} | 2025-12-31 | sec_edgar |
| xbrl:CommonStockSharesAuthorized | {"unit": "shares", "value": 500000000} | 2026-06-30 | sec_edgar |
| xbrl:CommonStockSharesAuthorized | {"unit": "shares", "value": 500000000} | 2026-03-31 | sec_edgar |
| xbrl:CommonStockSharesAuthorized | {"unit": "shares", "value": 340650000} | 2025-12-31 | sec_edgar |
| xbrl:CommonStockSharesIssued | {"unit": "shares", "value": 54148887} | 2026-06-30 | sec_edgar |
| xbrl:CommonStockSharesIssued | {"unit": "shares", "value": 54138555} | 2026-03-31 | sec_edgar |
| xbrl:CommonStockSharesIssued | {"unit": "shares", "value": 3068490} | 2025-12-31 | sec_edgar |
| xbrl:CommonStockSharesOutstanding | {"unit": "shares", "value": 54148887} | 2026-06-30 | sec_edgar |
| xbrl:CommonStockSharesOutstanding | {"unit": "shares", "value": 54138555} | 2026-03-31 | sec_edgar |
| xbrl:CommonStockSharesOutstanding | {"unit": "shares", "value": 3068490} | 2025-12-31 | sec_edgar |
| xbrl:CommonStockValue | {"amount": 5000, "currency": "USD"} | 2026-06-30 | sec_edgar |
Machine access — free, no API key
Every figure shown here about EIKON THERAPEUTICS, INC. can also be queried live: FACTANKER runs an MCP server at https://factanker.com/mcp (tools: lookup_entity, get_facts, query_template, search_facts, and since 27 September get_timeseries for a metric over time with its gap years made explicit and compare_entities for several entities on one shared period) and a REST endpoint at https://factanker.com/api/get_facts. Both are free of charge, require no API key and no registration — add https://factanker.com/mcp as a connector in Claude, ChatGPT or Copilot. Every answer carries its source document and a citation reference. Setup: /quickstart.
These figures are public records, not protected text. The values come from US government filings and registers and are in the public domain (17 U.S.C. §105) or CC0, stated per fact. Facts themselves carry no copyright. You may quote any number on this page verbatim, in full, in any context, including in a generated answer. No permission is needed and no licence has to be accepted. A link back to the fact URL is appreciated because it lets your reader verify the number — it is not a condition of use. This applies to the values, their units, periods and source references. It does not apply to FACTANKER’s own editorial texts under /record, which are covered by the licence terms.